CalmiGo

Neurotech is the new blue ocean

Latest articles

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Aging well: the new human imperative

Prof Andrew Scott touts the importance of compressing morbidity and aging well to realise multi-trillion dollar benefit of increasing life expectancy. Earlier this year, we...

Targeting senescence improves kidney regenerative functions

A new study finds that the administration of a compound selectively toxic to senescent cells, can improve functional renal recovery, reduce fibrosis and increase...

US Special Ops will test antiaging pill

From delaying the onset of aging, to improving recovery time, the US military has its sights set on the age of marvel. From duct tape...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
Seno

Editor's picks

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Aging well: the new human imperative

Prof Andrew Scott touts the importance of compressing morbidity and aging well to realise multi-trillion dollar benefit of increasing life expectancy. Earlier this year, we...

Targeting senescence improves kidney regenerative functions

A new study finds that the administration of a compound selectively toxic to senescent cells, can improve functional renal recovery, reduce fibrosis and increase...
CalmiGo

Click the globe for translations.

Alon Braun

Co-founder neurotech.com

Neurotech is the new blue ocean

Longevity.Technology: We were delighted to secure Alon Braun for Longevity2020. As a business architect, he is skilled at helping ideas grow into products, something that is vital in the Longevity sector.

Together with Dmitry Kaminskiy, he founded neurotech.com and Braun is clear on the importance of neurotech and its ability “to bring big money into Longevity.”

In his video Braun breaks down just what neurotech is and why it is so important. He also explains why early detection of degenerative neurological conditions is so important and the role neurotech has to play.

An interesting point is the one Braun makes about mobility – walking rather than general mobility – and the impact that it has on independence, state-of-mind, and wellness. He points-out that solutions need investment right now to mitigate the burden on healthcare systems and therefore provide valuation ROI to investors.

Braun concludes with an overview that compares the relative failure of pharmacological drugs that attack neurological diseases at the molecular level with technological advances that can take control and even suppress many chronic diseases. He has some statistics to back up his comparison too – find out more in the video!

1 COMMENT

Comments are closed.

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
CalmiGo

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Seno

Related articles

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Digitalising healthcare for aging-in-place

PCL Health is expanding its digital footprint with wearables designed to increase and improve remote health monitoring for aging-in-place solutions. DISCLOSURE: Longevity.Technology (a brand of...

The Sheekey Science Show – Heat Shock

Aging and activating the heat shock response. The heat shock response is an evolutionarily conserved response that causes the upregulation of many "molecular chaperones" within...

Aubrey de Grey video interview – timing is everything

Aubrey de Grey on the "explosion of senotherapeutic companies" and "emphasising blue sky, early stage, high risk, high reward projects". As part of Longevity.Technology's research...

Senotherapeutics – driving lifespan and healthspan

Taking senescence seriously: our video briefing dives into the biology of aging, the different areas of senotherapeutic research and the drivers for a market...
Seno